Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ia trial of RVX 208 in volunteers.

Trial Profile

Phase Ia trial of RVX 208 in volunteers.

Phase of Trial: Phase I

Latest Information Update: 31 Mar 2009

At a glance

  • Drugs Apabetalone (Primary)
  • Indications Acute coronary syndromes; Alzheimer's disease; Atherosclerosis; Low HDL cholesterol
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Mar 2009 Results presented at ACC 2009.
    • 10 Nov 2008 Results presented at AHA 2008.
    • 10 Nov 2008 Resverlogix has reported positive results of an exploratory analysis of effects on amyloid-beta levels.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top